Hédia Brixi

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

Laurent Beaugerie, Magali Svrcek, Philippe Seksik et al. · Gastroenterology · 2013 · 353 citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +10

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie et al. · Gut · 2017 · 315 citations · Full text

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht et al. · Gastroenterology · 2018 · 295 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Infliximab Dose +8

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Pauline Wils, Yoram Bouhnik, Pierre Michetti et al. · Clinical Gastroenterology and Hepatology · 2015 · 169 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +8

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Driffa Moussata, Matthieu Allez, Dominique Cazals‐Hatem et al. · Gut · 2017 · 163 citations